Clinical Trials Directory

Trials / Recruiting

RecruitingNCT02801253

Cohort of Prosthetic Joint Infections

Prospective Cohort of Patients With Prosthetic Joint Infection

Status
Recruiting
Phase
Study type
Observational
Enrollment
800 (estimated)
Sponsor
Groupe Hospitalier Diaconesses Croix Saint-Simon · Academic / Other
Sex
All
Age
18 Years
Healthy volunteers
Not accepted

Summary

Management of prosthetic joint infections (PJI) is a challenging task. These infections include different clinical and microbiological settings calling upon various treatment strategies according to infection type (acute or chronic), bone quality, the involved micro-organism and the patient's general condition and willing. Treatment of PJI combines surgery and prolonged antibiotic therapy. In some patients with a high operative risk prolonged suppressive antibiotic therapy can be used. Lack of large prospective studies motivated the conception of this cohort with a long term follow up, regardless to PJI management procedures.

Detailed description

Large prospective cohort study in a French referral center for bone and joint infections. Population * all patients who consented to participate in the study with PJI treated with: * debridement-synovectomy for acute infection * with one-stage, two-stage exchange arthroplasty for chronic infection * other procedures (complete removal of the prosthesis) and antibiotic therapy * patients (non-operated or operated) receiving prolonged suppressive antibiotic therapy Outcome: * Follow-up at least 2 years * Events monitored: reinfection including relapse and new infection, joint revision for mechanical failure, PJI related or non-related death Study duration: 10 years. Recruitment period: 4 years. Maximal duration of data collection: 6 years. Investigator center: monocenter study. Mean patient inclusion per year: 100 patients per year.

Conditions

Timeline

Start date
2015-09-11
Primary completion
2025-09-01
Completion
2029-09-01
First posted
2016-06-15
Last updated
2022-03-29

Locations

1 site across 1 country: France

Source: ClinicalTrials.gov record NCT02801253. Inclusion in this directory is not an endorsement.